Search

Author/Creator Kipps, Thomas

1. A phase II study of the combination of rituximab and granulocyte macrophage colony stimulating factor as treatment of patients with chronic lymphocytic leukemia. Issue 6 (June 2015)

Authors:
Strati, Paolo; Tong, Wei-Gang; Vitale, Candida; Wierda, William G.; O'Brien, Susan; Brown, Jennifer R.; Weng, Wen-Kai; Kipps, Thomas; Keating, Michael J.; Ferrajoli, Alessandra
Journal:
Leukemia & lymphoma
Issue:
Volume 56:Issue 6(2015:Jun.)
Page Start:
1878
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Dynamic changes in CCL3 and CCL4 plasma concentrations in patients with chronic lymphocytic leukaemia managed with observation. (21st October 2016)

Authors:
Sivina, Mariela; Werner, Lillian; Rassenti, Laura; Ferrajoli, Alessandra; Wierda, William G.; Keating, Michael J.; O'Brien, Susan; Neuberg, Donna; Kipps, Thomas; Burger, Jan A.
Journal:
British journal of haematology
Issue:
Volume 180:Number 4(2018)
Page Start:
597
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Safety and disease response to MEDI-551, an anti-CD19 antibody, in chronic lymphocytic leukemia patients previously treated with rituximab. (7th November 2013)

Authors:
Forero, Andres; Hamadani, Mehdi; Kipps, Thomas; Fanale, Michelle; Cuneo, Antonio; Perez de Oteyza, Jaime; Gladstone, Douglas; Andre, Marc; Bellam, Naresh; Goswami, Trishna; Ibrahim, Ramy; Schneider, Amy; Liang, Meina; Eck, Steven; Elgeioushi, Nairouz; Herbst, Ronald; Cheson, Bruce D
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 1(2013)Supplement 1
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗